RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…
1,508 followers
3,473 followers
RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…
1,451 followers
RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…
3,409 followers
RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…